Status:

COMPLETED

Neural Mobilization on Multiple Sclerosis

Lead Sponsor:

Kahramanmaras Sutcu Imam University

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Current treatments for pain in MS patients include the use of non-pharmacological interventions such as electrotherapy and exercise, as well as pharmacological treatments. Neurodynamic mobilization ex...

Detailed Description

Multiple Sclerosis (MS) is a chronic neurological disease characterized by local inflammation, gliosis and demyelination in the central nervous system (CNS). It is characterized by demyelinating plaqu...

Eligibility Criteria

Inclusion

  • Being diagnosed with MS according to McDonald 2010 diagnostic criteria
  • Being between the ages of 18-65
  • Volunteering to participate in the study

Exclusion

  • Being under 18 years of age and over 65 years of age
  • Having a history of trauma within the last year
  • Having alcohol and substance addiction
  • Having diabetes mellitus
  • Having another known neurological disease
  • Being pregnant

Key Trial Info

Start Date :

September 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06153264

Start Date

September 15 2023

End Date

July 15 2024

Last Update

August 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kahramanmaras Sutcu Imam University

Kahramanmaraş, Turkey (Türkiye)